SWOG S2012: 1L Chemo +/- Atezolizumab in Advanced Extrapulmonary Neuroendocrine Carcinoma

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

SWOG S2012: 1L Chemo +/- Atezolizumab in Advanced Extrapulmonary Neuroendocrine Carcinoma

By Fred Hutchinson Cancer Center FEATURING David Zhen

135 views

August 15, 2024

Comments 0

Treatment Decisions When Initiating a Tyrosine Kinase Inhibitor and …

Feat. K. Hanna, J. Strauss

Hypothetical Patient Case: Hepatocellular Carcinoma and Consideratio…

Feat. J. Gutierrez, J. Strauss

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

1.2K views

7 months ago

Neuroendocrine Tumors: Management and Updates

Integrity CE

R. Iyer

551 views

3 months ago

New

GI Cancers: Hot Topics in 2024

Yale Cancer Center

J. Lacy

373 views

3 weeks ago

Neuroendocrine Tumors in the GI Tract

Florida Gastroenterologic Society

A. Luthra

991 views

1 year ago

Tumor-Agnostic Efficacy & Safety of Selpercatinib in RET Fusion+ Sol…

UCSF School of Medicine

H. Kang

2.1K views

1 year ago

Sequencing Systemic Treatments for Well-Differentiated NETs

Integrity CE

J. Strosberg

242 views

7 months ago

2024 Updates on Targeted Approaches for GI Cancers and New Data in N…

Total Health

A. Grothey

246 views

8 months ago

Neuroendocrine Cancers: Background, Diagnosis, and Current Treatment

Total Health

R. Lentz

192 views

4 months ago

Imaging for Neuroendocrine Neoplasms

North American Neuroendocrine Tumor Society

G. Spilberg

115 views

1 month ago

MRD in GI Malignancies: Current Clinical Utility of ctDNA

Horizon CME

A. Scott

201 views

5 months ago

ESMO 2024 Summary: Treatment Strategies and Sequencing in Carcinoid …

2024 ESMO Annual Meeting Insights Hub

R. Riechelmann

101 views

1 month ago

ASCO® 2024 Insights: "212Pb-DOTAMTATE, a Targeted Alpha Therapy for …

2024 ASCO® Annual Meeting Insights Hub

J. Strosberg

201 views

5 months ago

NETs 101 and Overview of Medical Management

Yale Cancer Center

P. Kunz

350 views

11 months ago

New Developments in Neuroendocrine Tumor Treatment

Oncology Data Advisor

S. Kareff, A. Chauhan

168 views

8 months ago

Debates in NET Treatment: Surgery vs. IR for Liver-Limited Disease

Integrity CE

E. Liu

171 views

7 months ago

Medical Oncology Updates in NETs

2023 Johns Hopkins Updates in Gastrointestinal Cancers

P. Kunz

409 views

1 year ago

Role of Precision Medicine in the Treatment of Neuroendocrine Neopla…

University of Miami Sylvester Comprehensive Cancer Center

A. Chauhan

72 views

3 months ago

Pancreatic Adenocarcinoma and Neuroendocrine Tumors - An Update

AdventHealth

M. Tejani

83 views

1 month ago

Management of Poorly Differentiated Neuroendocrine Carcinomas

North American Neuroendocrine Tumor Society

J. Chan

88 views

2 months ago

Metastatic Grade 2 NET: Case Presentation and Panel Discussion

Integrity CE

A. De Jesus-Acosta, L. Bjork Solnes, J. Strosberg, E. Liu, R. Lidell

114 views

7 months ago

AUTOPLAY

Login

Login

Join VuMedi

SWOG S2012: 1L Chemo +/- Atezolizumab in Advanced Extrapulmonary Neuroendocrine Carcinoma

Treatment Decisions When Initiating a Tyrosine Kinase Inhibitor and …

Hypothetical Patient Case: Hepatocellular Carcinoma and Consideratio…

Recommended

Hyperprogression in Cancer Treated With Immunotherapy

Neuroendocrine Tumors: Management and Updates

GI Cancers: Hot Topics in 2024

Neuroendocrine Tumors in the GI Tract

Tumor-Agnostic Efficacy & Safety of Selpercatinib in RET Fusion+ Sol…

Sequencing Systemic Treatments for Well-Differentiated NETs

2024 Updates on Targeted Approaches for GI Cancers and New Data in N…

Neuroendocrine Cancers: Background, Diagnosis, and Current Treatment

Imaging for Neuroendocrine Neoplasms

MRD in GI Malignancies: Current Clinical Utility of ctDNA

ESMO 2024 Summary: Treatment Strategies and Sequencing in Carcinoid …

ASCO® 2024 Insights: "212Pb-DOTAMTATE, a Targeted Alpha Therapy for …

NETs 101 and Overview of Medical Management

New Developments in Neuroendocrine Tumor Treatment

Debates in NET Treatment: Surgery vs. IR for Liver-Limited Disease

Medical Oncology Updates in NETs

Role of Precision Medicine in the Treatment of Neuroendocrine Neopla…

Pancreatic Adenocarcinoma and Neuroendocrine Tumors - An Update

Management of Poorly Differentiated Neuroendocrine Carcinomas

Metastatic Grade 2 NET: Case Presentation and Panel Discussion